{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:01:14Z","timestamp":1740160874646,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To assess the change in vision-related quality of life and psychosocial well-being of the patients with episcleritis and scleritis patients before and after treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This one-and-a-half-year prospective study was conducted among 76 eyes of 71 new patients of episcleritis and scleritis. A structured questionnaire was used to assess the visual and to analyze the change in effect size. The male-to-female ratio was 1:1.536. Episcleritis was seen in 41 cases (57.7%) while scleritis was seen in 30 cases (42.3%). Patients with episcleritis had statistically significant improvement in general function score (GF) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) using paired t-test. The effect size showed medium improvement (approximately 0.5). Whereas there was no statistically significant change in psychosocial impact (PI), visual symptoms (VS) scoring, and a total score (p\u2009&lt;\u20090.05) using paired t-test. The effect size showed no improvement for PI and total score and small improvement for VS score. Patients with scleritis had statistically significant improvement in general function score (GF), visual symptoms (VS) scoring and total score (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) using paired-t-test. The effect size showed medium improvement (approximately 0.5) for general function score (GF) and total score. However, the effect size showed only a small improvement (approximately 0.2) for psychosocial impact (PI) score.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>VisionRelated Quality of Life of patients with scleritis showed significant improvement following treatment unlike episcleritis indicating scleritis more adversely affecting psychosocial well-being.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12348-021-00265-z","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T20:02:52Z","timestamp":1632340972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Vision-related quality of life and psychosocial well-being of patients with episcleritis and scleritis: a neglected essence?"],"prefix":"10.1186","volume":"11","author":[{"given":"Apurva Ratna","family":"Tamrakar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8624-4433","authenticated-orcid":false,"given":"Ranju","family":"Kharel Sitaula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagun Narayan","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjita","family":"Bajracharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"issue":"12","key":"265_CR1","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1016\/S0161-6420(99)90543-2","volume":"106","author":"PJ McCluskey","year":"1999","unstructured":"McCluskey PJ, Watson PG, Lightman S et al (1999) Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology 106(12):2380\u20132386. https:\/\/doi.org\/10.1016\/S0161-6420(99)90543-2","journal-title":"Ophthalmology"},{"issue":"5","key":"265_CR2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1136\/bjo.2004.050732","volume":"89","author":"SK Gupta","year":"2005","unstructured":"Gupta SK, Viswanath K, Thulasiraj RD, Murthy GV, Lamping DL, Smith SC, Donoghue M, Fletcher AE (2005) The development of the Indian vision function questionnaire: field testing and psychometric evaluation. Br J Ophthalmol 89(5):621\u2013627. https:\/\/doi.org\/10.1136\/bjo.2004.050732","journal-title":"Br J Ophthalmol"},{"key":"265_CR3","first-page":"29","volume":"1","author":"Organization WH","year":"1947","unstructured":"Organization WH (1947) The constitution of the world health organization. WHO Chron 1:29","journal-title":"WHO Chron"},{"issue":"6861","key":"265_CR4","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1136\/bmj.305.6861.1074","volume":"305","author":"R Fitzpatrick","year":"1992","unstructured":"Fitzpatrick R, Fletcher A, Gore S, Jones D, Spiegelhalter D, Cox D (1992) Quality of life measures in health care. I: applications and issues in assessment. BMJ Br Med J 305(6861):1074\u20131077. https:\/\/doi.org\/10.1136\/bmj.305.6861.1074","journal-title":"BMJ Br Med J"},{"key":"265_CR5","doi-asserted-by":"crossref","unstructured":"Venkataraman A, Rathinam SR (2008) A pre-and post-treatment evaluation of vision-related quality of life in uveitis","DOI":"10.4103\/0301-4738.39662"},{"key":"265_CR6","volume-title":"Statistical power analysis for the behavioural sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J (1988) Statistical power analysis for the behavioural sciences. Hillside, NJ Lawrence Earlbaum Assoc"},{"issue":"3","key":"265_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.4103\/0974-9233.134675","volume":"21","author":"S Kaleemunnisha","year":"2014","unstructured":"Kaleemunnisha S, Sudharshan S, Biswas J (2014) Quality of life in non-infectious uveitis patients on immunosuppressive therapy. Middle East Afr J Ophthalmol 21(3):225\u2013231. https:\/\/doi.org\/10.4103\/0974-9233.134675","journal-title":"Middle East Afr J Ophthalmol"},{"key":"265_CR8","doi-asserted-by":"publisher","unstructured":"Massof RW, Rubin GS (2018) Visual Function Assessment Questionnaires. Surv Ophthalmol 45:531\u2013548. https:\/\/doi.org\/10.1016\/S0039-6257(01)00194-1","DOI":"10.1016\/S0039-6257(01)00194-1"},{"issue":"1","key":"265_CR9","first-page":"65","volume":"48","author":"R Dandona","year":"2000","unstructured":"Dandona R, Dandona L, McCarty C, Rao G (2000) Adaptation of WHOQOL as health-related quality of life instrument to develop a vision-specific instrument. Indian J Ophthalmol 48(1):65\u201370","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"265_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146956","volume":"11","author":"L Hoeksema","year":"2016","unstructured":"Hoeksema L, Los LI (2016) Vision-related quality of life in patients with inactive HLA-B27-associated-Spectrum anterior uveitis. PLoS One 11(1):e0146956. https:\/\/doi.org\/10.1371\/journal.pone.0146956","journal-title":"PLoS One"},{"issue":"5","key":"265_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09273948.2016.1264610","volume":"00","author":"NS Gamal","year":"2017","unstructured":"Gamal NS, Sitaula RK, Narayan D, Gamal NS (2017) Change in visual function in uveitis patients after treatment : an experience from Nepal change in visual function in uveitis patients after treatment : an experience from Nepal. Ocul Immunol Inflamm 00(5):1\u20136. https:\/\/doi.org\/10.1080\/09273948.2016.1264610","journal-title":"Ocul Immunol Inflamm"},{"key":"265_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ajo.2017.04.003","volume":"179","author":"KM Niemeyer","year":"2017","unstructured":"Niemeyer KM, Gonzales JA, Rathinam SR, Babu M, Thundikandy R, Kanakath A, Porco TC, Browne EN, Rao MM, Acharya NR (2017) Quality-of-life outcomes from a randomized clinical trial comparing antimetabolites for intermediate, posterior, and Panuveitis. Am J Ophthalmol 179:10\u201317. https:\/\/doi.org\/10.1016\/j.ajo.2017.04.003","journal-title":"Am J Ophthalmol"},{"key":"265_CR13","doi-asserted-by":"crossref","unstructured":"Sugar EA, Venugopal V, Thorne JE, et al (2017) Longitudinal vision-related quality of life for patients with noninfectious uveitis treated with fluocinolone acetonide implant or systemic corticosteroid therapy. Ophthalmology 124:1662\u20139.","DOI":"10.1016\/j.ophtha.2017.05.015"},{"key":"265_CR14","doi-asserted-by":"crossref","unstructured":"Kempen JH, Altaweel MM, Drye LT, et al (2015) Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Intraocular Implant for Intermediate, Posterior or Panuveitis: 54 month results of The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow. Ophthalmology 2015;122:1976\u201386.","DOI":"10.1016\/j.ophtha.2015.06.043"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-021-00265-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12348-021-00265-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-021-00265-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T20:03:39Z","timestamp":1632341019000},"score":1,"resource":{"primary":{"URL":"https:\/\/joii-journal.springeropen.com\/articles\/10.1186\/s12348-021-00265-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["265"],"URL":"https:\/\/doi.org\/10.1186\/s12348-021-00265-z","relation":{},"ISSN":["1869-5760"],"issn-type":[{"type":"electronic","value":"1869-5760"}],"subject":[],"published":{"date-parts":[[2021,9,22]]},"assertion":[{"value":"29 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was acquired from Institutional Review Committee of Institute of Medicine. And informed written consent was obtained for the patients\u2019 participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from the Institutional Review Committee of Institute of Medicine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}